相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hsp90 Orchestrates Temperature-Dependent Candida albicans Morphogenesis via Ras1-PKA Signaling
Rebecca S. Shapiro et al.
CURRENT BIOLOGY (2009)
Monoclonal antibody-mediated inhibition of adhesion of Candida albicans and Candida dubliniensis to human epithelial cells
Natalia Elguezabal et al.
EUROPEAN JOURNAL OF ORAL SCIENCES (2009)
Monoclonal antibodies specific for Candida albicans Als3 that immunolabel fungal cells in vitro and in vivo and block adhesion to host surfaces
David A. Coleman et al.
JOURNAL OF MICROBIOLOGICAL METHODS (2009)
Characteristics of Fc-independent human antimannan antibody-mediated alternative pathway initiation of C3 deposition to Candida albicans
Gayle M. Boxx et al.
MOLECULAR IMMUNOLOGY (2009)
Protection by Anti-β-Glucan Antibodies Is Associated with Restricted β-1,3 Glucan Binding Specificity and Inhibition of Fungal Growth and Adherence
Antonella Torosantucci et al.
PLOS ONE (2009)
Treatment of a critically ill child with disseminated Candida glabrata with a recombinant human antibody specific for fungal heat shock protein 90 and liposomal amphotericin B, caspofungin, and voriconazole
Adam Sutherland et al.
Pediatric Critical Care Medicine (2009)
Harnessing Hsp90 function as a powerful, broadly effective therapeutic strategy for fungal infectious disease
Leah E. Cowen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Usefulness of biological markers in the diagnosis of invasive candidiasis
Jose Ponton
REVISTA IBEROAMERICANA DE MICOLOGIA (2009)
A novel monoclonal antibody recognizing β(1-3) glucans in intact cells of Candida and Cryptococcus
N. Kondori et al.
APMIS (2008)
Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group
Ben De Pauw et al.
CLINICAL INFECTIOUS DISEASES (2008)
Anti-beta-glucan-like immunoprotective candidacidal antiidiotypic antibodies
Walter Magliani et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2008)
Antibody-mediated Prevention of Fusarium Mycotoxins in the Field
Zu-Quan Hu et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2008)
Efungumab and caspofungin: pre-clinical data supporting synergy
Samantha Hodgetts et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Fungal vaccines: real progress from real challenges
Antonio Cassone
LANCET INFECTIOUS DISEASES (2008)
Antibody Complementarity-Determining Regions (CDRs) Can Display Differential Antimicrobial, Antiviral and Antitumor Activities
Luciano Polonelli et al.
PLOS ONE (2008)
Synthetic glycopeptide vaccines combining β-mannan and peptide epitopes induce protection against candidiasis
Hong Xin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Mechanisms of resistance to antifungal agents: Yeasts and filamentous fungi
Ana Espinel-Ingroff
REVISTA IBEROAMERICANA DE MICOLOGIA (2008)
Well-characterized monoclonal antibodies against cell wall antigen of Aspergillus species improve immunoassay specificity and sensitivity
Wei Hao et al.
CLINICAL AND VACCINE IMMUNOLOGY (2008)
An anti-β-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neofonnans in vitro and exerts therapeutic, anticryptococcal activity in vivo
Anna Rachini et al.
INFECTION AND IMMUNITY (2007)
Monoclonal antibody to fungal glucosylceramide protects mice against lethal Cryptococcus neoformans infection
Marcio L. Rodrigues et al.
CLINICAL AND VACCINE IMMUNOLOGY (2007)
Fungicidal monoclonal antibody C7 binds to Candida albicans Als3
Sonia Brena et al.
INFECTION AND IMMUNITY (2007)
Multicenter retrospective development and validation of a clinical prediction rule for nosocomial invasive candidiasis in the intensive care setting
L. Ostrosky-Zeichner et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2007)
Host defence against C-albicans infections in IgH transgenic mice with VH derived from a natural anti-keratin antibody
Wei Li et al.
CELLULAR MICROBIOLOGY (2007)
Antibody constructs in cancer therapy - Protein engineering strategies to improve exposure in solid tumors
Robert A. Beckman et al.
CANCER (2007)
Human domain antibodies against virulence traits of Candida albicans inhibit fungus adherence to vaginal epithelium and protect against experimental vaginal candidiasis
Flavia De Bernardis et al.
JOURNAL OF INFECTIOUS DISEASES (2007)
Epidemiology of invasive candidiasis: a persistent public health problem
M. A. Pfaller et al.
CLINICAL MICROBIOLOGY REVIEWS (2007)
Advances in combating fungal diseases: vaccines on the threshold
Jim E. Cutler et al.
NATURE REVIEWS MICROBIOLOGY (2007)
Opportunistic fungi and fungal infections: the challenge of a single, general antifungal vaccine
Antonio Cassone et al.
EXPERT REVIEW OF VACCINES (2006)
Mycograb for the treatment of invasive candidiasis
Raoul Herbrecht et al.
CLINICAL INFECTIOUS DISEASES (2006)
Inhibition of filamentation can be used to treat disseminated candidiasis
Stephen P. Saville et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2006)
Human recombinant antibody against Candida
Helen Elizabeth Rowlands et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2006)
Vaccinations with recombinant variants of Aspergillus fumigatus allergen Asp f 3 protect mice against invasive aspergillosis
James I. Ito et al.
INFECTION AND IMMUNITY (2006)
Protective immune responses against systemic candidiasis mediated by phage-displayed specific epitope of Candida albicans heat shock protein 90 in C57BL/6J mice
Guiyun Wang et al.
VACCINE (2006)
A randomized, blinded, multicenter trial of lipid-associated amphotericin B alone versus in combination with an antibody-based inhibitor of heat shock protein 90 in patients with invasive candidiasis
J Pachl et al.
CLINICAL INFECTIOUS DISEASES (2006)
A fungicidal monoclonal antibody protects against murine invasive candidiasis
MJ Sevilla et al.
INFECTION AND IMMUNITY (2006)
Active immunization against Pneumocystis carinii with a recombinant P-catinii antigen
J Wells et al.
INFECTION AND IMMUNITY (2006)
A bedside scoring system (Candida score'') for early antifungal treatment in nonneutropenic critically ill patients with Candida colonization
C León et al.
CRITICAL CARE MEDICINE (2006)
Candidacidal activity of a monoclonal antibody that binds with glycosyl moieties of proteins of Candida albicans
A Kavishwar et al.
MEDICAL MYCOLOGY (2006)
Recombinant single-chain anti-idiotypic antibody: An effective fungal beta-1,3-glucan synthase inhibitor
Dakshnamurthy Selvakumar et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2006)
Human recombinant antimannan immunoglobulin G1 antibody confers resistance to hematogenously disseminated candidiasis in mice
MX Zhang et al.
INFECTION AND IMMUNITY (2006)
Fungal heat-shock proteins in human disease
JR Burnie et al.
FEMS MICROBIOLOGY REVIEWS (2006)
Polysaccharide-containing conjugate vaccines for fungal diseases
A Casadevall et al.
TRENDS IN MOLECULAR MEDICINE (2006)
Hsp90 potentiates the rapid evotution of new traits: Drug resistance in diverse fungi
LE Cowen et al.
SCIENCE (2005)
A novel glyco-conjugate vaccine against fungal pathogens
A Torosantucci et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Prophylactic vaccination with phage-displayed epitope of C-albicans elicits protective immune responses against systemic candidiasis in C57BL/6 mice
Q Yang et al.
VACCINE (2005)
Defining criteria for anti-mannan antibodies to protect against Candidiasis
JE Cutler
CURRENT MOLECULAR MEDICINE (2005)
An outline of the role of anti-Candida antibodies within the context of passive immunization and protection from candidiasis
A Cassone et al.
CURRENT MOLECULAR MEDICINE (2005)
Role of anti-β-glucan antibody in host defense against fungi
K Ishibashi et al.
FEMS IMMUNOLOGY AND MEDICAL MICROBIOLOGY (2005)
Phase I evaluation of the safety and pharmacokinetics of murine-derived anticryptococcal antibody 18B7 in subjects with treated cryptococcal meningitis
RA Larsen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2005)
Vaccination with recombinant N-terminal domain of Als1p improves survival during murine disseminated candidiasis by enhancing cell-mediated, not humoral, immunity
AS Ibrahim et al.
INFECTION AND IMMUNITY (2005)
Epidemiology of candidemia in Swiss tertiary care hospitals:: Secular trends, 1991-2000
O Marchetti et al.
CLINICAL INFECTIOUS DISEASES (2004)
New concepts in antibody-mediated immunity
A Casadevall et al.
INFECTION AND IMMUNITY (2004)
Therapeutic activity of a killer peptide against experimental paracoccidioidomycosis
LR Travassos et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2004)
Biological activities of naturally occurring antibodies reactive with Candida albicans mannan
TR Kozel et al.
INFECTION AND IMMUNITY (2004)
Melanin from Fonsecaea pedrosoi induces production of human antifungal antibodies and enhances the antimicrobial efficacy of phagocytes
DS Alviano et al.
INFECTION AND IMMUNITY (2004)
Epidemiology of Candida species infections in critically ill non-immunosuppressed patients
P Eggimann et al.
LANCET INFECTIOUS DISEASES (2003)
A monoclonal antibody directed against a Candida albicans cell wall mannoprotein exerts three anti-C-albicans activities
MD Moragues et al.
INFECTION AND IMMUNITY (2003)
Preclinical assessment of the efficacy of mycograb, a human recombinant antibody against fungal HSP90
RC Matthews et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2003)
Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2003)
Enhanced phagocytosis of Candida species mediated by opsonization with a recombinant human antibody single-chain variable fragment
M Wellington et al.
INFECTION AND IMMUNITY (2003)
Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis
L Polonelli et al.
INFECTION AND IMMUNITY (2003)
Attributable mortality of nosocomial candidemia, revisited
O Gudlaugsson et al.
CLINICAL INFECTIOUS DISEASES (2003)
Deeply invasive candidiasis
L Ostrosky-Zeichner et al.
INFECTIOUS DISEASE CLINICS OF NORTH AMERICA (2002)
Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated candidiasis in recipients of a Candida albicans vaccine
C Bromuro et al.
INFECTION AND IMMUNITY (2002)
Localization within a proline-rich antigen (Ag2/PRA) of protective antigenicity against infection with Coccidioides immitis in mice
T Peng et al.
INFECTION AND IMMUNITY (2002)
Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation
E Cenci et al.
INFECTION AND IMMUNITY (2002)
Passive intranasal monoclonal antibody prophylaxis against murine Pneumocystis carinii pneumonia
F Gigliotti et al.
INFECTION AND IMMUNITY (2002)
Role of glucan and surface protein BAD1 in complement activation by Blastomyces dermatitidis yeast
MX Zhang et al.
INFECTION AND IMMUNITY (2001)
Complement is essential for protection by an IgM and an IgG3 monoclonal antibody against experimental, hematogenously disseminated candidiasis
YM Han et al.
JOURNAL OF IMMUNOLOGY (2001)
Passive immunization with melanin-binding monoclonal antibodies prolongs survival of mice with lethal Cryptococcus neoformans infection
AL Rosas et al.
INFECTION AND IMMUNITY (2001)
Protection against candidiasis by an immunoglobulin G3 (IgG3) monoclonal antibody specific for the same mannotriose as an IgM protective antibody
Y Han et al.
INFECTION AND IMMUNITY (2000)
分享论文
